Concepts (190)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Dehydration | 1 | 2017 | 15 | 0.580 |
Why?
|
| Hypernatremia | 1 | 2017 | 7 | 0.580 |
Why?
|
| Hyponatremia | 1 | 2017 | 20 | 0.570 |
Why?
|
| Aging | 3 | 2017 | 911 | 0.540 |
Why?
|
| Homeostasis | 1 | 2017 | 291 | 0.510 |
Why?
|
| Renal Replacement Therapy | 2 | 2013 | 40 | 0.500 |
Why?
|
| Kidney Diseases | 2 | 2017 | 307 | 0.480 |
Why?
|
| Scedosporium | 1 | 2013 | 2 | 0.440 |
Why?
|
| Pipecolic Acids | 1 | 2013 | 9 | 0.440 |
Why?
|
| Mediastinitis | 1 | 2013 | 4 | 0.440 |
Why?
|
| Antithrombins | 1 | 2013 | 32 | 0.430 |
Why?
|
| Blood Coagulation | 1 | 2013 | 123 | 0.420 |
Why?
|
| Mycoses | 1 | 2013 | 60 | 0.420 |
Why?
|
| Coronary Artery Bypass | 2 | 2013 | 218 | 0.410 |
Why?
|
| Sepsis | 1 | 2013 | 233 | 0.350 |
Why?
|
| Brachial Artery | 1 | 2007 | 34 | 0.300 |
Why?
|
| Vasodilation | 1 | 2007 | 85 | 0.290 |
Why?
|
| Postoperative Complications | 1 | 2013 | 1615 | 0.250 |
Why?
|
| Coronary Vessels | 1 | 2007 | 313 | 0.250 |
Why?
|
| Obesity | 2 | 2011 | 1076 | 0.230 |
Why?
|
| Kidney Transplantation | 2 | 2021 | 839 | 0.220 |
Why?
|
| Nephrolithiasis | 2 | 2013 | 9 | 0.210 |
Why?
|
| Receptors, Interleukin-2 | 1 | 2021 | 42 | 0.190 |
Why?
|
| Pharmacology, Clinical | 1 | 2021 | 13 | 0.190 |
Why?
|
| Clinical Medicine | 1 | 2021 | 20 | 0.190 |
Why?
|
| Hypertension | 2 | 2007 | 1535 | 0.180 |
Why?
|
| Tacrolimus | 1 | 2021 | 127 | 0.170 |
Why?
|
| Glomerular Filtration Rate | 3 | 2016 | 274 | 0.170 |
Why?
|
| Interprofessional Relations | 1 | 2021 | 188 | 0.170 |
Why?
|
| Patient Care Team | 1 | 2021 | 311 | 0.160 |
Why?
|
| Phagocytes | 1 | 1997 | 15 | 0.150 |
Why?
|
| Arteriosclerosis | 1 | 1997 | 137 | 0.150 |
Why?
|
| Immunosuppressive Agents | 1 | 2021 | 514 | 0.150 |
Why?
|
| Src Homology 2 Domain-Containing, Transforming Protein 1 | 1 | 2017 | 15 | 0.140 |
Why?
|
| Ubiquinone | 1 | 2017 | 14 | 0.140 |
Why?
|
| Son of Sevenless Proteins | 1 | 2016 | 4 | 0.140 |
Why?
|
| Exome | 1 | 2016 | 20 | 0.140 |
Why?
|
| Renal Insufficiency, Chronic | 2 | 2009 | 161 | 0.140 |
Why?
|
| Kidney Tubules, Proximal | 1 | 2017 | 81 | 0.140 |
Why?
|
| Primary Health Care | 2 | 2013 | 703 | 0.140 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2016 | 56 | 0.140 |
Why?
|
| Elastin | 1 | 1997 | 116 | 0.140 |
Why?
|
| Genetic Loci | 2 | 2016 | 59 | 0.140 |
Why?
|
| Peptide Fragments | 1 | 1997 | 483 | 0.130 |
Why?
|
| Humans | 22 | 2021 | 68618 | 0.130 |
Why?
|
| Atherosclerosis | 3 | 2011 | 204 | 0.120 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2016 | 411 | 0.120 |
Why?
|
| Phosphorylcholine | 1 | 2013 | 12 | 0.110 |
Why?
|
| GTP-Binding Proteins | 1 | 1993 | 231 | 0.100 |
Why?
|
| Arginine | 1 | 2013 | 102 | 0.100 |
Why?
|
| Antifungal Agents | 1 | 2013 | 108 | 0.100 |
Why?
|
| Sulfonamides | 1 | 2013 | 141 | 0.100 |
Why?
|
| Kidney | 1 | 2016 | 945 | 0.100 |
Why?
|
| Middle Aged | 10 | 2013 | 21147 | 0.100 |
Why?
|
| P-Selectin | 1 | 2011 | 16 | 0.100 |
Why?
|
| Heart Ventricles | 2 | 2007 | 738 | 0.100 |
Why?
|
| Carotid Arteries | 1 | 2011 | 110 | 0.100 |
Why?
|
| Kidney Calculi | 1 | 2010 | 19 | 0.090 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2012 | 142 | 0.090 |
Why?
|
| Blood Platelets | 1 | 2011 | 284 | 0.090 |
Why?
|
| Apoptosis | 1 | 2017 | 1641 | 0.090 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2012 | 786 | 0.080 |
Why?
|
| Male | 10 | 2013 | 37321 | 0.080 |
Why?
|
| Kidney Failure, Chronic | 2 | 2009 | 365 | 0.080 |
Why?
|
| Terminology as Topic | 1 | 2009 | 141 | 0.080 |
Why?
|
| Neutrophils | 3 | 1997 | 204 | 0.080 |
Why?
|
| Nitroglycerin | 1 | 2007 | 20 | 0.080 |
Why?
|
| Nitroprusside | 1 | 2007 | 42 | 0.070 |
Why?
|
| Tomography, Emission-Computed | 1 | 2007 | 40 | 0.070 |
Why?
|
| Data Collection | 1 | 2009 | 420 | 0.070 |
Why?
|
| Hospitalization | 2 | 2010 | 978 | 0.070 |
Why?
|
| Arterioles | 1 | 2007 | 40 | 0.070 |
Why?
|
| Renal Dialysis | 1 | 2008 | 174 | 0.070 |
Why?
|
| Vasodilator Agents | 1 | 2007 | 138 | 0.070 |
Why?
|
| Bradykinin | 1 | 2007 | 157 | 0.070 |
Why?
|
| Aged | 6 | 2012 | 14862 | 0.070 |
Why?
|
| Intensive Care Units | 1 | 2008 | 344 | 0.070 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2007 | 237 | 0.060 |
Why?
|
| Ultrasonography | 1 | 2007 | 453 | 0.060 |
Why?
|
| Acute Kidney Injury | 1 | 2008 | 232 | 0.060 |
Why?
|
| Incidence | 1 | 2009 | 1603 | 0.060 |
Why?
|
| Technetium Tc 99m Sestamibi | 1 | 2004 | 24 | 0.060 |
Why?
|
| Heart Aneurysm | 1 | 2004 | 21 | 0.060 |
Why?
|
| Myocardial Reperfusion | 1 | 2004 | 32 | 0.060 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2004 | 137 | 0.060 |
Why?
|
| Signal Transduction | 1 | 1993 | 2689 | 0.060 |
Why?
|
| Body Mass Index | 1 | 2007 | 867 | 0.060 |
Why?
|
| Bisoprolol | 1 | 2003 | 1 | 0.060 |
Why?
|
| Female | 9 | 2012 | 38074 | 0.060 |
Why?
|
| Benzopyrans | 1 | 2003 | 21 | 0.050 |
Why?
|
| Ethanolamines | 1 | 2003 | 33 | 0.050 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2003 | 189 | 0.050 |
Why?
|
| Maintenance Chemotherapy | 1 | 2021 | 10 | 0.050 |
Why?
|
| Adult | 7 | 2012 | 21403 | 0.050 |
Why?
|
| Induction Chemotherapy | 1 | 2021 | 39 | 0.050 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2004 | 450 | 0.040 |
Why?
|
| Superoxides | 2 | 1997 | 70 | 0.040 |
Why?
|
| Treatment Outcome | 2 | 2021 | 7029 | 0.040 |
Why?
|
| Creatinine | 2 | 2009 | 243 | 0.040 |
Why?
|
| Pancreatic Elastase | 1 | 1997 | 33 | 0.040 |
Why?
|
| Erythrocytes | 1 | 1997 | 137 | 0.040 |
Why?
|
| Cytochromes c | 1 | 2017 | 75 | 0.040 |
Why?
|
| Monocytes | 1 | 1997 | 210 | 0.030 |
Why?
|
| Receptors, Cell Surface | 1 | 1997 | 248 | 0.030 |
Why?
|
| Cholesterol | 1 | 1997 | 331 | 0.030 |
Why?
|
| Risk Factors | 3 | 2011 | 5731 | 0.030 |
Why?
|
| N-Formylmethionine Leucyl-Phenylalanine | 2 | 1993 | 7 | 0.030 |
Why?
|
| Comorbidity | 2 | 2011 | 1426 | 0.030 |
Why?
|
| Binding Sites | 1 | 1997 | 631 | 0.030 |
Why?
|
| Zebrafish | 1 | 2016 | 187 | 0.030 |
Why?
|
| Genome-Wide Association Study | 1 | 2016 | 240 | 0.030 |
Why?
|
| Biomarkers | 2 | 2011 | 1593 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2021 | 2007 | 0.030 |
Why?
|
| Antioxidants | 1 | 2017 | 304 | 0.030 |
Why?
|
| Cross-Sectional Studies | 2 | 2011 | 2279 | 0.030 |
Why?
|
| Reactive Oxygen Species | 1 | 2017 | 499 | 0.030 |
Why?
|
| Electronic Nicotine Delivery Systems | 1 | 2017 | 180 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2017 | 1200 | 0.030 |
Why?
|
| Cohort Studies | 2 | 2011 | 2358 | 0.030 |
Why?
|
| Inositol 1,4,5-Trisphosphate | 1 | 1993 | 13 | 0.030 |
Why?
|
| Adenosine Diphosphate Ribose | 1 | 1993 | 14 | 0.030 |
Why?
|
| Cholera Toxin | 1 | 1993 | 30 | 0.030 |
Why?
|
| Virulence Factors, Bordetella | 1 | 1993 | 60 | 0.030 |
Why?
|
| Nicotine | 1 | 2017 | 350 | 0.030 |
Why?
|
| Pertussis Toxin | 1 | 1993 | 72 | 0.030 |
Why?
|
| Molecular Weight | 1 | 1993 | 358 | 0.030 |
Why?
|
| United States | 3 | 2010 | 7367 | 0.030 |
Why?
|
| Oxidative Stress | 1 | 2017 | 718 | 0.030 |
Why?
|
| Lymphocytes | 1 | 1993 | 228 | 0.030 |
Why?
|
| Genetic Association Studies | 1 | 2012 | 103 | 0.030 |
Why?
|
| In Vitro Techniques | 1 | 1993 | 765 | 0.030 |
Why?
|
| Polysomnography | 1 | 2012 | 92 | 0.030 |
Why?
|
| Mitochondria | 1 | 2017 | 643 | 0.030 |
Why?
|
| Urologic Surgical Procedures | 1 | 2012 | 47 | 0.020 |
Why?
|
| Cell-Derived Microparticles | 1 | 2011 | 5 | 0.020 |
Why?
|
| Platelet Activation | 1 | 2011 | 24 | 0.020 |
Why?
|
| Alleles | 1 | 2012 | 386 | 0.020 |
Why?
|
| Carotid Intima-Media Thickness | 1 | 2011 | 54 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2011 | 159 | 0.020 |
Why?
|
| Gallstones | 1 | 2010 | 58 | 0.020 |
Why?
|
| Genotype | 1 | 2012 | 786 | 0.020 |
Why?
|
| Polymorphism, Genetic | 1 | 2011 | 301 | 0.020 |
Why?
|
| Triglycerides | 1 | 2010 | 184 | 0.020 |
Why?
|
| Time Factors | 2 | 2008 | 4655 | 0.020 |
Why?
|
| Blood Pressure | 2 | 2008 | 1451 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2012 | 627 | 0.020 |
Why?
|
| Phenotype | 1 | 2012 | 947 | 0.020 |
Why?
|
| Animals | 2 | 2017 | 20881 | 0.020 |
Why?
|
| Epidemiologic Methods | 1 | 2009 | 83 | 0.020 |
Why?
|
| Mississippi | 1 | 2009 | 11 | 0.020 |
Why?
|
| International Classification of Diseases | 1 | 2009 | 85 | 0.020 |
Why?
|
| Hemodialysis Solutions | 1 | 2008 | 3 | 0.020 |
Why?
|
| Acute-Phase Proteins | 1 | 2008 | 13 | 0.020 |
Why?
|
| Rats | 1 | 2017 | 5300 | 0.020 |
Why?
|
| Smoking | 1 | 2017 | 1452 | 0.020 |
Why?
|
| Blood Volume | 1 | 2008 | 47 | 0.020 |
Why?
|
| Urea | 1 | 2008 | 51 | 0.020 |
Why?
|
| Albuminuria | 1 | 2009 | 171 | 0.020 |
Why?
|
| Enkephalin, Methionine | 1 | 1988 | 20 | 0.020 |
Why?
|
| Lipoxygenase | 1 | 1988 | 13 | 0.020 |
Why?
|
| Hungary | 1 | 2007 | 10 | 0.020 |
Why?
|
| Databases as Topic | 1 | 2007 | 49 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2010 | 1046 | 0.020 |
Why?
|
| Echocardiography, Three-Dimensional | 1 | 2007 | 38 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2012 | 772 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2010 | 1054 | 0.020 |
Why?
|
| Oxygen Consumption | 1 | 1988 | 258 | 0.020 |
Why?
|
| Sex Factors | 1 | 2010 | 1266 | 0.020 |
Why?
|
| Patient Education as Topic | 1 | 2009 | 425 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2009 | 955 | 0.020 |
Why?
|
| Prevalence | 1 | 2009 | 1619 | 0.010 |
Why?
|
| Logistic Models | 1 | 2008 | 1420 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 1993 | 4848 | 0.010 |
Why?
|
| Nebivolol | 1 | 2003 | 6 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2008 | 1330 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2009 | 3705 | 0.010 |
Why?
|
| Coronary Artery Disease | 1 | 2007 | 696 | 0.010 |
Why?
|
| Adolescent | 1 | 1993 | 8912 | 0.010 |
Why?
|
| Masoprocol | 1 | 1988 | 3 | 0.000 |
Why?
|
| Glutathione Reductase | 1 | 1988 | 17 | 0.000 |
Why?
|
| Leukotriene B4 | 1 | 1988 | 17 | 0.000 |
Why?
|
| NADH, NADPH Oxidoreductases | 1 | 1988 | 19 | 0.000 |
Why?
|
| Glutathione Peroxidase | 1 | 1988 | 39 | 0.000 |
Why?
|
| Arachidonic Acid | 1 | 1988 | 86 | 0.000 |
Why?
|
| Naloxone | 1 | 1988 | 56 | 0.000 |
Why?
|
| Arachidonic Acids | 1 | 1988 | 97 | 0.000 |
Why?
|
| Indomethacin | 1 | 1988 | 107 | 0.000 |
Why?
|
| NADPH Oxidases | 1 | 1988 | 80 | 0.000 |
Why?
|
| Enzyme Activation | 1 | 1988 | 791 | 0.000 |
Why?
|
| Glutathione | 1 | 1988 | 343 | 0.000 |
Why?
|